News from Zyme and the companies we work with.
H.E.L Group Appoints Professor Yih-Shing Duh as Chief Scientific Advisor
Expert in battery testing further strengthens H.E.L’s expertise in thermal safety Professor Duh will be delivering two seminars on behalf of H.E.L Group on 11-12th July at Xiamen University, demonstrating [...]
Optibrium Demonstrates Accelerated Lead Optimisation in Complex Agrochemical Development
Optibrium’s QuanSA 3D-QSAR method uses an active learning approach to successfully and more efficiently identify a mimic of a macrocyclic natural product CAMBRIDGE, UK, 2nd July 2024 – Optibrium, a [...]
Cellular Origins Acquires ACTIA Platform IP to enhance automated cell therapy manufacturing
Autologous Cell Therapy Industrial Automation (ACTIA) strengthens technology and IP portfolio of Cellular Origins supporting ongoing development and expanding capabilities of Constellation platform CAMBRIDGE, UK, 02 July 2024: Cellular Origins, [...]
Bio-Rad Launches ChemiDoc Go Imaging System for Highly Sensitive Benchtop Gel and Western Blot Imaging
Compact System Uses CMOS Digital Imaging and Is Compatible with Chemiluminescence and Fluorescence Detection and Stain-Free Technology HERCULES, Calif. — July 1, 2024 — Bio-Rad Laboratories, Inc. (NYSE: BIO and [...]
Bio-Rad Launches Celselect Slides 2.0 to Advance Rare Cell and Circulating Tumor Cell Enrichment for Cancer Research
New Celselect Slides™ Design Increases Efficiency of Circulating Tumor Cell Capture from Liquid Biopsy Samples for Enumeration and Downstream Applications HERCULES, Calif. — June 27, 2024 — Bio-Rad Laboratories, Inc. [...]
CN Bio appoints Lydia Seymour as VP People and Culture to further strengthen leadership team
Key appointment to support continued UK and US team expansion Cambridge, UK, 27 June 2024: CN Bio, a leading provider of single- and multi-organ microphysiological systems, today announced the appointment [...]
Sapio Sciences Introduces Sapio GMP LIMS Offering Unmatched Flexibility for Unique Manufacturing Processes
Sapio Sciences announces key new capabilities to its highly flexible, no/low-code LIMS to support laboratories that must comply with GMP, 21 CFR 11, and EU Annex 11 standards Baltimore, MD, [...]
Bio-Rad Extends Range of Anti-Biotherapeutic Antibodies to Accelerate Antibody Drug Development
Four New Anti-Idiotypic Antibodies and a New Anti-MMAE Antibody Range Support Bioanalytical Assay Development for Preclinical Research and Clinical Trials HERCULES, Calif. — June 24, 2024 — Bio-Rad Laboratories, Inc. [...]
Bio-Rad Launches ddSEQ™ Single-Cell 3′ RNA-Seq Kit for Single-Cell Gene Expression
ddSEQ™ Single-Cell 3' RNA-Seq Kit and Omnition v1.1 Analysis Software Enable High-Quality and Affordable Single-Cell Transcription and Gene Expression to Support Molecular Biology, Oncology, and Drug Discovery Research HERCULES, Calif. [...]
Gyros Protein Technologies introduces Gyrolab Generic Anti-AAV Kit to support gene therapy development
Ready-to-use kit enables detection of binding antibodies against AAV vectors without the need for serotype-specific assays Uppsala, Sweden, 17 June 2024: Gyros Protein Technologies AB, a pioneer in automated nanoliter-scale [...]
Enterprise Therapeutics appoints Dr Renu Gupta as Chief Medical Officer and Dr Janet Hammond as Non-Executive Director
Appointments bring additional respiratory and late clinical-stage drug development experience as Company commences Phase 2a clinical trial of its lead asset Brighton, UK, 17 June 2024: Enterprise Therapeutics Ltd (Enterprise), [...]
Sphere Fluidics awarded Gold accreditation by Investors in People
Internationally-recognized ‘We invest in people’ award is certified recognition of the Company’s care and commitment to its employees globally Cambridge, UK, 14 June, 2024: Sphere Fluidics, a leading provider of [...]
